HIV-1 Infection
Showing 1 - 25 of >10,000
HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))
Not yet recruiting
- HIV-1-infection
- Low-dose STP0404 (Pirmitegravir)
- +3 more
- (no location specified)
May 16, 2023
HIV, HIV Pre-exposure Prophylaxis Trial (MK-8527, Placebo to MK-8527)
Not yet recruiting
- HIV
- HIV Pre-exposure Prophylaxis
- MK-8527
- Placebo to MK-8527
- (no location specified)
Sep 21, 2023
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022
Optimising Cohorts for HIV Cure Interventions
Recruiting
- HIV-1-infection
- no intervention
-
Prahran, Victoria, AustraliaAlfred Health
May 1, 2023
HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)
Not yet recruiting
- HIV-1-infection
- HIV Seropositivity
- Leucapheresis
-
Gent, Oost-Vlaanderen, BelgiumUZ Gent
Jul 25, 2023
Observational PIC Destination Cohort
Not yet recruiting
- HIV-1-infection
- (no location specified)
Aug 14, 2023
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
HIV-1-infection, Sexually Transmitted Diseases Trial in Madrid (Description)
Completed
- HIV-1-infection
- Sexually Transmitted Diseases
- Description
-
Madrid, SpainHospital Universitario Infanta Leonor
Aug 16, 2023
HIV-1-infection Trial in Ghent (Dual versus triple therapy in treatment of HIV-1 infection.)
Recruiting
- HIV-1-infection
- Dual versus triple therapy in treatment of HIV-1 infection.
-
Ghent, BelgiumGhent University Hospital
Dec 5, 2022
HIV-1-infection, Metabolic Syndrome Trial (physical activity)
Not yet recruiting
- HIV-1-infection
- Metabolic Syndrome
- physical activity
- (no location specified)
Jun 6, 2023
Pertussis Immunization During Pregnancy & HIV Infection
Completed
- Immunization; Infection
- +3 more
- TDaP
-
Brussels, Belgium
- +1 more
Sep 29, 2022
Quantification of Antisense HIV RNA in Patients
Recruiting
- HIV-1-infection
- Blood sampling
-
Paris, FranceJean-Paul VIARD
Dec 21, 2022
Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- Islatravir
- Placebo
- (no location specified)
Oct 13, 2022
HIV-1-infection Trial (FMT capsules, Placebo capsules)
Not yet recruiting
- HIV-1-infection
- FMT capsules
- Placebo capsules
- (no location specified)
Aug 31, 2023
HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)
Not yet recruiting
- HIV-1-infection
- +2 more
- CAB + RPV
- (no location specified)
Nov 16, 2022
HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)
Completed
- HIV-1-infection
- BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
-
Madrid, SpainHospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022
New Treatment Strategies in Eastern European Region and in
Recruiting
- HIV-1-infection
-
Cologne, Germany
- +3 more
Nov 10, 2023
HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)
Not yet recruiting
- HIV-1-infection
- +4 more
- FT538
- Vorinostat
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 31, 2023
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023